Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00169663 · ClinicalTrials.gov registry record
Brushite Kidney Stones: A Registry and Database of Clinical and Laboratory Findings
A clinical trial of Nephrolithiasis, sponsored by Indiana Kidney Stone Institute.
- Completed
- Registry status
- 90
- Enrollment target
- 1
- Study location
NCT00169663 is a study of Nephrolithiasis that has completed, run by Indiana Kidney Stone Institute. The registered enrollment target is 90 participants, below the 119-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00169663, a study of Nephrolithiasis, has completed, sponsored by Indiana Kidney Stone Institute.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Brushite kidney stones are a unique form of calcium phosphate stones that have a tendency to recur quickly if patients are not aggressively treated with stone prevention measures. Little research has been undertaken to better understand the clinical history and potential urinary abnormalities that may predispose one to these troublesome kidney stones.
Conditions Studied
Study Locations (1)
Indiana
- Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2003-07 |
| Est. Completion | 2010-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00169663
The ClinicalTrials.gov registry entry for NCT00169663 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 119-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (24% lower). The listed sponsor is Indiana Kidney Stone Institute, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nephrolithiasis appearing as the primary indexed condition, and to 0 interventions.
NCT00169663 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT00169663 about?
NCT00169663 is a clinical study titled "Brushite Kidney Stones: A Registry and Database of Clinical and Laboratory Findings". Brushite kidney stones are a unique form of calcium phosphate stones that have a tendency to recur quickly if patients are not aggressively treated with stone prevention measures. Little research has been undertaken to better understand the clinical history and potential urinary abnormalities that m...
What is the current status of trial NCT00169663?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2003-07. Estimated completion is 2010-11.
What conditions does trial NCT00169663 study?
This clinical trial studies the following conditions: Nephrolithiasis.
Who is sponsoring clinical trial NCT00169663?
This trial is sponsored by Indiana Kidney Stone Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00169663 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nephrolithiasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.
RECRUITING
-
Evaluation of Genetic Abnormalities Amongst Calcium Phosphate Stone Formers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.